Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

1.

Intraductal papillary mucinous adenocarcinoma of the pancreas: clinical outcomes, prognostic factors, and the role of adjuvant therapy.

Alexander BM, Fernandez-Del Castillo C, Ryan DP, Kachnic LA, Hezel AF, Niemierko A, Willett CG, Kozak KR, Blaszkowsky LS, Clark JW, Warshaw AL, Hong TS.

Gastrointest Cancer Res. 2011 Jul;4(4):116-21.

PMID:
22368734
[PubMed]
Free PMC Article
2.

Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes.

Wasif N, Bentrem DJ, Farrell JJ, Ko CY, Hines OJ, Reber HA, Tomlinson JS.

Cancer. 2010 Jul 15;116(14):3369-77. doi: 10.1002/cncr.25070.

PMID:
20564064
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas.

Poultsides GA, Reddy S, Cameron JL, Hruban RH, Pawlik TM, Ahuja N, Jain A, Edil BH, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL.

Ann Surg. 2010 Mar;251(3):470-6. doi: 10.1097/SLA.0b013e3181cf8a19.

PMID:
20142731
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Systematic review and meta-analysis comparing the surgical outcomes of invasive intraductal papillary mucinous neoplasms and conventional pancreatic ductal adenocarcinoma.

Koh YX, Chok AY, Zheng HL, Tan CS, Goh BK.

Ann Surg Oncol. 2014 Aug;21(8):2782-800. doi: 10.1245/s10434-014-3639-0. Epub 2014 Apr 1.

PMID:
24687151
[PubMed - in process]
5.

Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy.

Turrini O, Waters JA, Schnelldorfer T, Lillemoe KD, Yiannoutsos CT, Farnell MB, Sarr MG, Schmidt CM.

HPB (Oxford). 2010 Sep;12(7):447-55. doi: 10.1111/j.1477-2574.2010.00196.x.

PMID:
20815853
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage.

Waters JA, Schnelldorfer T, Aguilar-Saavedra JR, Chen JH, Yiannoutsos CT, Lillemoe KD, Farnell MB, Sarr MG, Schmidt CM.

J Am Coll Surg. 2011 Aug;213(2):275-83. doi: 10.1016/j.jamcollsurg.2011.04.003. Epub 2011 May 20.

PMID:
21601488
[PubMed - indexed for MEDLINE]
7.

Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas.

Swartz MJ, Hsu CC, Pawlik TM, Winter J, Hruban RH, Guler M, Schulick RD, Cameron JL, Laheru DA, Wolfgang CL, Herman JM.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):839-44. doi: 10.1016/j.ijrobp.2009.02.071. Epub 2009 Aug 3.

PMID:
19647950
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry.

Worni M, Akushevich I, Gloor B, Scarborough J, Chino JP, Jacobs DO, Hahn SM, Clary BM, Pietrobon R, Shah A.

Ann Surg Oncol. 2012 Apr;19(4):1316-23. doi: 10.1245/s10434-011-2088-2. Epub 2011 Oct 15.

PMID:
22002799
[PubMed - indexed for MEDLINE]
9.

Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival.

Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB.

Ann Surg Oncol. 2006 Apr;13(4):582-94. Epub 2006 Mar 7.

PMID:
16523362
[PubMed - indexed for MEDLINE]
10.

Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.

Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A, Sueda T.

J Surg Oncol. 2009 Jul 1;100(1):13-8. doi: 10.1002/jso.21290.

PMID:
19384908
[PubMed - indexed for MEDLINE]
11.

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD.

Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9.

PMID:
15166958
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients.

Adsay NV, Conlon KC, Zee SY, Brennan MF, Klimstra DS.

Cancer. 2002 Jan 1;94(1):62-77.

PMID:
11815961
[PubMed - indexed for MEDLINE]
Free Article
13.

Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms.

Caponi S, Vasile E, Funel N, De Lio N, Campani D, Ginocchi L, Lucchesi M, Caparello C, Lencioni M, Cappelli C, Costa F, Pollina L, Ricci S, Mosca F, Falcone A, Boggi U.

Eur J Surg Oncol. 2013 Apr;39(4):396-403. doi: 10.1016/j.ejso.2012.12.005. Epub 2013 Jan 3.

PMID:
23290583
[PubMed - indexed for MEDLINE]
14.

Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.

Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Yoon YB.

Pancreas. 2008 Jan;36(1):50-5. doi: 10.1097/MPA.0b013e31812575df.

PMID:
18192881
[PubMed - indexed for MEDLINE]
15.

Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome.

D'Angelica M, Brennan MF, Suriawinata AA, Klimstra D, Conlon KC.

Ann Surg. 2004 Mar;239(3):400-8.

PMID:
15075659
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Identification of patients with high-risk stage II colon cancer for adjuvant therapy.

Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Landmann RG, Guillem JG, Paty PB, Temple LK, Wong WD, Weiser MR.

Dis Colon Rectum. 2008 May;51(5):503-7. doi: 10.1007/s10350-008-9246-z. Epub 2008 Mar 6.

PMID:
18322753
[PubMed - indexed for MEDLINE]
17.

High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound.

Wong J, Weber J, Centeno BA, Vignesh S, Harris CL, Klapman JB, Hodul P.

J Gastrointest Surg. 2013 Jan;17(1):78-84; discussion p.84-5. doi: 10.1007/s11605-012-2017-0. Epub 2012 Sep 5.

PMID:
22948841
[PubMed - indexed for MEDLINE]
18.

Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma.

Shimada K, Sakamoto Y, Sano T, Kosuge T, Hiraoka N.

Pancreas. 2006 Apr;32(3):281-7.

PMID:
16628084
[PubMed - indexed for MEDLINE]
19.

Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.

Estrella JS, Rashid A, Fleming JB, Katz MH, Lee JE, Wolf RA, Varadhachary GR, Pisters PW, Abdalla EK, Vauthey JN, Wang H, Gomez HF, Evans DB, Abbruzzese JL, Wang H.

Cancer. 2012 Jan 1;118(1):268-77. doi: 10.1002/cncr.26243. Epub 2011 Jul 6.

PMID:
21735446
[PubMed - indexed for MEDLINE]
Free Article
20.

MSX2 in pancreatic tumor development and its clinical application for the diagnosis of pancreatic ductal adenocarcinoma.

Satoh K, Hamada S, Shimosegawa T.

Front Physiol. 2012 Nov 14;3:430. doi: 10.3389/fphys.2012.00430. eCollection 2012.

PMID:
23162473
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk